Most Recent Articles by Tori Rodriguez, MA, LPC
Although metformin has been studied in randomized trials as adjunctive therapy to insulin in individuals with type 1 diabetes, further investigation in the form of outcomes trials is necessary to assess risks vs benefits.
Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.
Emerging evidence shows promise regarding the potential role of precision nutrition in the prevention and management of T2D. However, considerably more research is needed before this approach can be widely applied for these purposes.
Long-distance air travel presents numerous unique challenges for insulin-treated patients with diabetes. More accessible and adequate sources of guidance are needed to facilitate travel planning among this patient population.
Kevin Pantalone, DO, from the Cleveland Clinic, provides insight into the management of gastrointestinal symptoms in patients with diabetes.
More Articles by Tori Rodriguez, MA, LPC
Endocrinology Advisor Articles
- Single Blood Sample Highly Predictive for Subsequent Diabetes Diagnosis
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk
- Fenofibrate Improves Cholesterol Levels in Type 2 Diabetes
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- CDC: Obesity Prevalence Higher in Non-Metropolitan Counties
- Vascular Mortality Declining in Adults With Diabetes in the United States
- CVS Pharmacy Launches Prescription Delivery Service Nationwide
- Led by AG Sessions, DOJ Declines to Defend ACA Against Federal Lawsuit
- Kidney Function Decline Occurs Nearly Twice as Fast in Diabetes